Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
|
Tauroselcholic acid (75-Se) 370 kBq oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
|
Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
1 |
Tauroselcholic acid (75-Se) 370 kBq oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
1 |
Tauroselcholic acid (75-Se) 370 kBq oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
1 |
Radionuclide imaging of gastrointestinal tract using tauroselcholic acid (75-Se) |
Using substance (attribute) |
True |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
1 |
Radionuclide imaging of liver and/or biliary tract using tauroselcholic acid (75-Se) |
Using substance (attribute) |
False |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
1 |
Tauroselcholic acid (75-Se) 370 kBq oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
1 |
Radionuclide imaging of liver using tauroselcholic acid (75-Se) |
Using substance (attribute) |
True |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
1 |
Radionuclide imaging of biliary tract using tauroselcholic acid (75-Se) (procedure) |
Using substance (attribute) |
True |
Tauroselcholic acid (75-Se) (substance) |
Inferred relationship |
Some |
1 |